Progesterone Market Size, Share & Trends Analysis Report By Type (Natural Progesterone, Synthetic Progesterone), By Modes of Delivery Source: (Injectable, Suspended Form, Oral, Intravaginal, Others), By Application (Regulation of the Menstrual Cycle, Dysfunctional Uterine Bleeding, Endometrial Cancer, Contraception, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Progesterone Market Size

The global progesterone market size was valued at USD 1.94 billion in 2025 and is projected to grow from USD 2.12 billion in 2026 to USD 4.24 billion by 2034, registering a CAGR of 9.08% during the forecast period from 2026 to 2034. North America dominated the progesterone market with a market share of 38.4% in 2025.

Progesterone is a key steroid hormone that regulates the menstrual cycle, supports pregnancy and promotes embryo formation. Produced mainly in the ovaries after ovulation, it prepares the uterine lining for implantation and maintains it during early pregnancy, preventing contractions that could expel the embryo. The placenta takes over its production later in life. Progesterone is also produced in small amounts by the adrenal glands and is used clinically in hormone replacement therapy, contraception, and treating menstrual disorders. Proper progesterone levels are essential for reproductive health, with deficiencies leading to issues like irregular menstruation and difficulties in maintaining pregnancy.

The progesterone market is growing due to increasing demand for hormone replacement therapy (HRT) in menopausal women, rising prevalence of menstrual disorders, and the expanding use of progesterone in assisted reproductive technologies (ART). Market growth is also driven by growing awareness of women's health, advances in drug delivery systems and increased research and development into progesterone based therapies.

Type Insights

The global market is divided into natural progesterone and synthetic progesterone. The natural segment for progesterone market is dominant. Natural progesterone, which is identical to the progesterone produced in the human body, is often preferred over synthetic progesterone due to its perceived safety and effectiveness. Natural progesterone-based products are derived from soybeans or Dioscorea Villosa, a wild Mexican yam. The natural progesterone segment is leading in the global market, driven by rising product launches by various players in the industry.

• For example, Fuji Pharma Co., Ltd launched F-meno capsule 100 mg, a natural progesterone drug in Japan, for preventing endometrial hyperplasia associated with estrogen drugs. Positive patient outcomes with natural progesterone, attributed to improved hormonal interactions, contribute to its high growth potential.

Request Customizationto receive a tailored report.

Mode of Delivery Source Insights

The global market is divided into injectable, suspended form, oral, intravaginal and others. The oral mode of delivery source segment dominates the global market. Oral administration is often preferred by patients due to its convenience and practicality compared to IM injections or intravaginal administration.

• For example, as per an article published by National Library of Medicine, in some countries like India, women are reluctant to use intravaginal medications, especially during pregnancy, and prefer oral medication.

Moreover, in terms of safety and tolerability, oral progesterone preparations mitigate the risk of local adverse effects associated with intramuscular injections or intravaginal administration. This is attributed to the systemic absorption of the medication through the gastrointestinal tract, bypassing the need for direct application to localized areas.

Application Insights

The global market is bifurcated into regulation of the menstrual cycle, dysfunctional uterine bleeding, endometrial cancer, contraception, others. The regulation of the menstrual cycle segment dominates the global market. The high prevalence of menstrual disorders due to various factors, including stress, unhealthy lifestyle choices, obesity, hormonal disorders like PCOS and thyroid imbalances, as well as environmental and genetic factors is increasing the need of progesterone to address these disorders by regulating the menstrual cycle and hormone levels, alleviating associated symptoms.

• For example, a study published in the National Library of Medicine reported a high prevalence of menstrual disorders among females, with 90.4% experiencing some form of disorder. This included amenorrhea (39%), dysmenorrhea (70.8%), and premenstrual syndrome (72.2%). These study underscore the significant impact of menstrual disorders on a large portion of the female population and highlight the need for effective treatments and management strategies to regulate the cycle using progesterone.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America is the most significant global progesterone market shareholder and is expected to expand substantially during the forecast period due to various product launches in North America.

• For instance, Xiromed LLC, the generic division of Insud Pharmaceuticals based in Florham Park, NJ, announced the launch of Progesterone Injection USP, 500 mg/10 mL (50 mg/mL) Multiple-Dose Vial, a generic version of Progesterone Injection USP, 50 mg/mL.

United States Progesterone Market Trends

The United States market is leading in terms of market share. The increase in uterine body cancers in U.S. is expected to boost the market. The American Cancer Society estimates that in 2024, about 67,880 new cases of uterine cancer will be diagnosed in U.S. , with about 13,250 women dying from the disease. These figures underscore the importance of progesterone in the treatment and management of uterine cancer, contributing to the growth of the market.

Canada is expected to become a key player in the market. As per Canada.ca, in 2022, an estimated 28,600 Canadian women diagnosed with breast cancer, and 5,500 died. Breast cancer accounts for approximately 25% of new cases of cancer and 14% of all cancer deaths in Canadian women. These figures highlights the importance of progesterone, which is used in treating hormone-related cancers like breast cancer, indicating a potential rise in demand for such treatments in Canada.

Unlock Regional Insightsto access country-level data, & regional trends.

Europe Progesterone Market Trends

Europe region is expected to emerge in progesterone market. Europe has a well-established healthcare infrastructure and a high prevalence of conditions such as breast cancer and menstrual disorders, which are commonly treated with progesterone. Additionally, increasing awareness about women's health and advancements in medical research contribute to the region's prominence in the market.

U.K. progesterone market has a major role in shaping the dynamics of the Europe progesterone market. In the UK, progesterone is available in various forms and strengths for different indications. It is primarily prescribed as part of hormone replacement therapy (HRT) for menopausal symptoms, often in combination with estrogen.

• For instance, one of the leading manufacturers of progesterone-based products, Theramex launched Bijuva/Bijuve (1mg estradiol / 100mg progesterone) in Europe and the UK. It's the first body-identical hormone therapy (HRT) combining estradiol and progesterone in a single daily oral capsule for post-menopausal women with an intact uterus. This launch offers a new treatment option for estrogen deficiency symptoms in this population.

Germany is expected to emerge in the market. According to National Institutes of Health (NIH), endometrial cancer (EC) is the most commonly diagnosed gynecological cancer in Germany, with 12,356 new cases and 2444 deaths. Thus, rising the need for progesterone based treatment.

Moreover, key manufacturers in Germany such as Bayer are focused on producing various progesterone-based products, including Duphaston (dydrogesterone) for the treatment of menstrual disorders such as irregular periods and dysmenorrhea, as well as in hormone replacement therapy (HRT).

List of Key and Emerging Players in Progesterone Market